Xcout IntelSenseonics Holdings, Inc. competitors & alternatives
The 12 closest competitors and alternatives to Senseonics Holdings, Inc. among medical devices companies — ranked by similarity to what Senseonics Holdings, Inc. actually does, not by market-cap band.
Subscribe to see Senseonics Holdings, Inc.’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event
About Senseonics Holdings, Inc.
Senseonics Holdings, Inc. operates as a medical technology enterprise, specializing in the development and commercialization of continuous glucose monitoring (CGM) systems. These innovative solutions cater to individuals with diabetes across the United States, Europe, the Middle East, and Africa. The company's core product offerings, Eversense and Eversense XL, are advanced implantable CGM devices. They function by continuously tracking glucose levels through an under-the-skin sensor, a detachable and rechargeable smart transmitter, and an intuitive mobile application. This setup enables real-time diabetes monitoring and management for durations of up to half a year. Senseonics delivers its products and services to healthcare providers and patients alike via an extensive network of distributors and strategic fulfillment partners. Additionally, the firm maintains a collaborative agreement with the University Hospitals Accountable Care Organization. Founded in 1996, Senseonics Holdings, Inc. is headquartered in Germantown, Maryland.
Senseonics Holdings, Inc. at a glance
Senseonics Holdings, Inc. is a medical devices company headquartered in Germantown, United States. It is publicly listed (SENS) with a market capitalisation of $210.2M. Xcout tracks 37 named people at Senseonics Holdings, Inc., including Timothy T. Goodnow (President, Chief Executive Officer & Director).
Senseonics Holdings, Inc. leadership
- Timothy T. GoodnowPresident, Chief Executive Officer & Director
- Mukul JainChief Operating Officer
- Frederick T. SullivanChief Financial Officer, Secretary & Treasurer
- Rick SullivanChief Financial Officer
- Brian HansenChief Commercial Officer & Director
- Francine R. Kaufman, M.D.Chief Medical Officer
31 more named people on record for Senseonics Holdings, Inc., with roles, board committees and tenure — see the full roster →
Top 12 Senseonics Holdings, Inc. competitors
Ranked by semantic similarity — how close each company is to Senseonics Holdings, Inc. by what it does, using Xcout's live company graph. Click any company for its full profile, or its competitor set.
Similar medical devices company
DexCom, Inc. is a medical technology company primarily focused on innovating, developing, and marketing continuous glucose monitoring (CGM) systems. Operating across the United States and internationally, the firm provides its solutions for individuals managing diabetes as well as for healthcare practitioners. Its product portfolio features the DexCom G6, a comprehensive CGM system for diabetes management; the Dexcom Real-Time API, enabling authorized third-party developers to integrate live CGM data into their digital health applications; the Dexcom ONE, which aims to supersede traditional finger-prick blood glucose testing for treatment decisions; and Dexcom Share, a remote monitoring platform. The company is also developing the Dexcom G7, its next-generation CGM system. Furthermore, DexCom, Inc. has a licensing and collaboration agreement with Verily Life Sciences LLC and Verily Ireland Limited to advance blood-based or interstitial glucose monitoring products. The company directly sells its offerings to specialists such as endocrinologists, physicians, and diabetes educators. DexCom, Inc. was founded in 1999 and maintains its headquarters in San Diego, California.
Similar medical devices company
Sinocare manufactures and provides continuous glucose monitoring (CGM) systems and related mobile applications for diabetes management.
Similar medical devices company
Beta Bionics, Inc. is a commercial-stage medical technology company dedicated to inventing, developing, and bringing to market solutions that improve the health and quality of life for individuals with diabetes who depend on insulin. The company's flagship product, the iLet Bionic Pancreas, is an automated insulin delivery system currently available for treating type 1 diabetes in adults and children aged six and older. In addition to its existing offering, Beta Bionics is actively developing several new innovations: a Patch Pump, designed as a tubeless insulin pump that adheres directly to the skin; the Bihormonal iLet, which integrates automated delivery of both insulin and glucagon; and an iLet system specifically adapted for individuals with insulin-dependent type 2 diabetes. To support its product pipeline, the company has forged strategic alliances, including a collaboration and licensing agreement with Xeris Pharmaceuticals, Inc. to develop and commercialize a glucagon formulation compatible with pumps. It also holds a development and commercialization agreement with Abbott Diabetes Care Inc. for an automated insulin delivery system. Established in 2015, Beta Bionics is headquartered in Irvine, California.
Similar medical devices company
i-SENS is a South Korean global healthcare company specializing in the development and production of blood glucose monitoring systems, continuous glucose monitoring systems, and in-vitro diagnostics.
Similar medical devices company
Tandem Diabetes Care, Inc., a medical technology firm, specializes in creating, developing, and marketing solutions for individuals globally who manage insulin-dependent diabetes. At the core of its offerings is the t:slim X2 insulin delivery system, an advanced pump platform that integrates the t:slim X2 pump, a disposable 300-unit insulin cartridge, and an infusion set. Tandem further enhances this platform with innovative features like Basal-IQ and Control-IQ technology, as well as G5 Integration capabilities. The company also provides the Tandem Device Updater, enabling users to easily update their pump's software. To facilitate therapy management, Tandem offers t:connect, a web-based application that visually presents diabetes data from the pump, continuous glucose monitoring (CGM) devices, and supported blood glucose meters to patients, their caregivers, and healthcare professionals. Additionally, the Sugarmate mobile application caters specifically to insulin users with diabetes. Tandem has strategic development and commercialization partnerships with leading companies such as Dexcom, Inc. and Abbott Laboratories. Established in 2006 and headquartered in San Diego, California, the company was initially known as Phluid Inc. before rebranding as Tandem Diabetes Care, Inc. in January 2008.
Medical Devices & Healthcare
Pharmaco Healthcare provides diabetes management products and medical devices, including insulin pumps, continuous glucose monitors, and blood glucose meters in New Zealand.
Biotechnology & Medical Devices
HarmonIQ Biosciences Inc. develops continuous hormone monitoring wearable technology using an aptamer-based sensing platform. The company provides real-time, science-driven hormone data to help consumers and biopharma users track their health, performance, and longevity.
Similar medical devices company
Biobeat is a medical technology company that develops FDA-cleared, cuffless ambulatory blood pressure monitoring solutions. Their technology is designed to empower clinicians in the diagnosis and management of hypertension.
Similar medical devices company
Senzime AB (publ) is a medical technology company that develops and markets patient monitoring systems for clinical use, operating internationally with a US presence in St. Louis, Missouri.
Similar medical devices company
MicroTech Medical is a pioneer in the diabetes management medical devices industry, established in 2011 and located in the Hangzhou Future Sci-Tech City. The company specializes in the research, development, and manufacturing of diabetes glucose monitoring and treatment products.
Similar medical devices company
MicroTech Medical (Hangzhou) Co., Ltd. focuses on the innovation, production, and market distribution of essential medical devices and consumables for diabetes management. Its operations extend across the People's Republic of China and into global markets. The company offers a comprehensive range of products, including the Equil Patch insulin pump systems, AiDEX continuous glucose monitoring systems, POCT analyzer systems, traditional blood glucose monitoring systems, and advanced closed-loop artificial pancreas technology. Beyond its core offerings, MicroTech Medical is also actively involved in engineering and technological research, experimentation, and developmental endeavors. The firm, established in 2011, maintains its headquarters in Hangzhou, People's Republic of China.
Similar medical devices company
Ottai provides a continuous glucose monitoring system and companion app designed for 24/7 glucose tracking. The company serves individuals managing diabetes by offering wearable devices and AI-powered insights to help monitor glucose fluctuations and build healthier habits without the need for finger pricks.
Analyze another company
Search any company we track to see its competitive set.
Or describe a company
Paste a short paragraph describing a company or product — we'll find the most similar companies we track, scored 1–100.
See the full profile of Senseonics Holdings, Inc. and its market
Funding, investors, tech stack, hiring signals, leadership and corporate events — for Senseonics Holdings, Inc.and every competitor above — in one live dashboard.
Subscribe to Xcout Intel →